Literature DB >> 19290937

T-cell protein tyrosine phosphatase is a key regulator in immune cell signaling: lessons from the knockout mouse model and implications in human disease.

Karen M Doody1, Annie Bourdeau, Michel L Tremblay.   

Abstract

The immune system requires for its proper ontogeny, differentiation, and maintenance the function of several tyrosine kinases and adapters that create and modify tyrosine phosphorylation sites. Tyrosine phosphorylation is a crucial protein modification in immune cell signaling and can be reversed by protein tyrosine phosphatases (PTPs). Much progress has been made in identifying and understanding PTP function in the immune system. In this review, we present one of these proteins, named T-cell PTPs (TC-PTP) (gene name PTPN2), a classical, non-receptor PTP that is ubiquitously expressed with particularly high expression in hematopoietic tissues. TC-PTP is remarkable not only by the fact that it appears to influence most, if not all, cells involved in the development of the immune system, from stem cells to differentiated lineages, but also recent findings have positioned it at the core of several human diseases from autoimmune disease to cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19290937     DOI: 10.1111/j.1600-065X.2008.00743.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  44 in total

Review 1.  Molecular and cellular pathobiology of Ehrlichia infection: targets for new therapeutics and immunomodulation strategies.

Authors:  Jere W McBride; David H Walker
Journal:  Expert Rev Mol Med       Date:  2011-01-31       Impact factor: 5.600

Review 2.  Animal models of IBD: linkage to human disease.

Authors:  Atsushi Mizoguchi; Emiko Mizoguchi
Journal:  Curr Opin Pharmacol       Date:  2010-06-08       Impact factor: 5.547

3.  Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia.

Authors:  Maria Kleppe; Idoya Lahortiga; Tiama El Chaar; Kim De Keersmaecker; Nicole Mentens; Carlos Graux; Katrien Van Roosbroeck; Adolfo A Ferrando; Anton W Langerak; Jules P P Meijerink; François Sigaux; Torsten Haferlach; Iwona Wlodarska; Peter Vandenberghe; Jean Soulier; Jan Cools
Journal:  Nat Genet       Date:  2010-05-16       Impact factor: 38.330

4.  A polymorphism in PTPN2 gene is associated with an earlier onset of type 1 diabetes.

Authors:  Laura Espino-Paisan; Hermenegildo de la Calle; Miguel Fernández-Arquero; Maria Angeles Figueredo; Emilio G de la Concha; Elena Urcelay; Jose Luis Santiago
Journal:  Immunogenetics       Date:  2011-01-19       Impact factor: 2.846

5.  Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin's lymphoma and T-cell non-Hodgkin's lymphoma.

Authors:  Maria Kleppe; Thomas Tousseyn; Eva Geissinger; Zeynep Kalender Atak; Stein Aerts; Andreas Rosenwald; Iwona Wlodarska; Jan Cools
Journal:  Haematologica       Date:  2011-07-26       Impact factor: 9.941

Review 6.  Autologous regulatory T cells for the treatment of type 1 diabetes.

Authors:  James A Thompson; Daniel Perry; Todd M Brusko
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

Review 7.  Role of protein tyrosine phosphatases in regulating the immune system: implications for chronic intestinal inflammation.

Authors:  Marianne R Spalinger; Declan F McCole; Gerhard Rogler; Michael Scharl
Journal:  Inflamm Bowel Dis       Date:  2015-03       Impact factor: 5.325

8.  PTPN2 controls differentiation of CD4⁺ T cells and limits intestinal inflammation and intestinal dysbiosis.

Authors:  M R Spalinger; S Kasper; C Chassard; T Raselli; I Frey-Wagner; C Gottier; S Lang; K Atrott; S R Vavricka; F Mair; B Becher; C Lacroix; M Fried; G Rogler; M Scharl
Journal:  Mucosal Immunol       Date:  2014-12-10       Impact factor: 7.313

9.  Increased susceptibility to dextran sulfate sodium induced colitis in the T cell protein tyrosine phosphatase heterozygous mouse.

Authors:  Syed-Wajahat Hassan; Karen M Doody; Serge Hardy; Noriko Uetani; Denis Cournoyer; Michel L Tremblay
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

10.  Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.

Authors:  S Alice Long; Karen Cerosaletti; Paul L Bollyky; Megan Tatum; Heather Shilling; Sheng Zhang; Zhong-Yin Zhang; Catherine Pihoker; Srinath Sanda; Carla Greenbaum; Jane H Buckner
Journal:  Diabetes       Date:  2009-10-29       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.